PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAYtm ...
Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
More than 20% of Hawai‘i residents are over the age of 65 years old, possibly making them more at risk for eye diseases, ...
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.
Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...
D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.
Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...